Calcium Entry Blockers in Migraine: The State of the Art
The calcium entry blockers or calcium antagonists are a group of medications that share the potential of inhibiting the movement of calcium into cells and cell organelles. They do so through a number of different mechanisms, such as, for instance, the blockade of potential- or receptor-operated calcium channels or the blockade of calcium influx under conditions of overload. Chemically the calcium entry blockers represent medications of different groups with little or no relationship to each other and little or no predictability with regard to activity and/or mechanism .
KeywordsIschemia Migraine Nitrite Neurol Cardiol
Unable to display preview. Download preview PDF.
- 1.Amery WK, Wauquier A, Van Neuten JM, DeClerck F, Van Treempts JV, Janssen PAJ (1981) The anti-migrainous pharmacology of flunarizine (R14950), a calcium antagonist. Drugs Exp Clin Res 7:1–10Google Scholar
- 4.Gardner-Medwin AR (1981) The effect of carbon dioxide and oxygen on Leão’s spreading depression: evidence supporting a relationship to migraine. J Physiol 316:23P–24PGoogle Scholar
- 9.Lauritzen M, Olsen TS, Lassen NA, Paulson OB (1983) Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol 633–641Google Scholar
- 17.Olsen TS, Friberg L, Ronager J (1987) Cerebrovascular reactivity is completely abolished during attacks of classic migraine. Cephalalgia 7 (Suppl 6): 103–105Google Scholar
- 18.Spierings ELH (1987) Cluster headache: distinguishing features. Drug Therapy 17(5): 56–67Google Scholar
- 19.Spierings ELH (1987) Cluster headache: relieving and preventing attacks. Drug Therapy 17(5):68–72Google Scholar
- 20.Spierings ELH (1987) Migraine headaches: mechanisms and management. New Dev Med 2:59–76Google Scholar
- 23.Spierings ELH, Messinger HB (1988) Flunarizine versus pizotifen in migraine prophylaxis: a review of comparative studies. Cephalalgia (in press)Google Scholar